These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Physical problems in organ activity measurements after administration of radiochromium. Experiments on models]. Wolf R; Fischer J Nucl Med (Stuttg); 1963; 2():Suppl 1:195-20. PubMed ID: 5900112 [No Abstract] [Full Text] [Related]
24. [Study of the life-span of erythrocytes labeled with Cr51 in patients with chronic hepatitis or splenomegalic cirrhosis]. Gheorghescu B; Merculiev E; Timiş E; Mardale D; Dan M Med Interna (Bucur); 1966 Jun; 18(6):711-9. PubMed ID: 5965384 [No Abstract] [Full Text] [Related]
27. [Erythrocyte life span in certain hepatolienal diseases]. Sokolova GM Klin Med (Mosk); 1972 Nov; 50(11):119-23. PubMed ID: 4666692 [No Abstract] [Full Text] [Related]
28. [Erythrocyte survival in hemolytic anemias]. Neumann W; Siering H; Correns HJ; Unverricht A Z Gesamte Inn Med; 1969 Nov; 24(22):797-801. PubMed ID: 5368510 [No Abstract] [Full Text] [Related]
29. Contribution to the study of various splenomegalies in a tropical environment by means of radiochromium. Sprumont P Trop Geogr Med; 1966 Mar; 18(1):1-9. PubMed ID: 5957114 [No Abstract] [Full Text] [Related]
30. [The modern theory of hypersplenism on the basis of cytokinetic findings]. Pöttgen W Dtsch Med Wochenschr; 1972 Jul; 97(29):1100-2. PubMed ID: 5043311 [No Abstract] [Full Text] [Related]
31. Erythrokinetic effect of parental spleen cells in hybrid mice. Bain GO Arch Pathol; 1965 Oct; 80(4):397-408. PubMed ID: 5836482 [No Abstract] [Full Text] [Related]
32. [STUDY OF THE BLOOD VOLUME AND ERYTHROCYTE SURVIVAL IN THE AGED SUBJECT BY CHROMIUM-51]. CUNY G; MICHAUD G; DUHEILLE J; GUERCI O Rev Fr Gerontol; 1964 Jun; 10():217-20. PubMed ID: 14176679 [No Abstract] [Full Text] [Related]
33. [Clinical studies on sequestration function of the spleen. II. Quantitative estimation of the spleen volume by scintigraphy and examination of its function with damaged cell clearance]. Takahashi Y Nihon Ketsueki Gakkai Zasshi; 1967 Dec; 30(7):983-1009. PubMed ID: 5628229 [No Abstract] [Full Text] [Related]
34. [The duration of erythrocyte survival in patients with cirrhosis of the liver. (Studies using Cr51)]. Meshiné EN Med Radiol (Mosk); 1965 Sep; 10(9):57-62. PubMed ID: 5870438 [No Abstract] [Full Text] [Related]
36. [Portal hypertension in sarcoidosis. Three cases including one with liver fibrosis and malignant hepatoma with osseous stroma (author's transl)]. Leger L; Lemaigre G; Prémont M; Salmon R; Klioua Z; Battesti JP Nouv Presse Med; 1980 Mar; 9(14):1021-4. PubMed ID: 6245404 [TBL] [Abstract][Full Text] [Related]
37. [Estimation and clinical significance of the surface activity measurement following radiochromium labeling of erythrocytes]. Heimpel H; Hoffmann G; Keiderling W Nucl Med (Stuttg); 1963; 2():Suppl 1:201-12. PubMed ID: 5900113 [No Abstract] [Full Text] [Related]
38. The blood volume in post-necrotic cirrhosis of the liver with splenomegaly. McFadzean AJ; Todd D Clin Sci; 1967 Jun; 32(3):339-50. PubMed ID: 6028118 [No Abstract] [Full Text] [Related]
39. Determination of erythrocyte half life and blood volume in cats. Spink RR; Malvin RL; Cohen BJ Am J Vet Res; 1966 Jul; 27(119):1041-3. PubMed ID: 6007731 [No Abstract] [Full Text] [Related]
40. INFLUENCE OF SPLEEN SIZE AND PORTAL PRESSURE ON ERYTHROCYTE SEQUESTRATION. HOLZBACH RT; SHIPLEY RA; CLARK RE; CHUDZIK EB J Clin Invest; 1964 Jun; 43(6):1125-35. PubMed ID: 14171790 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]